Yanling Chen

5.8k citations
126 papers · 2.6k indexed · 1 hit paper · h-index 25

Impact in

    • RNA modifications and cancer
    • Bacterial biofilms and quorum sensing
    • RNA and protein synthesis mechanisms
    • Ubiquitin and proteasome pathways
    • Protein Degradation and Inhibitors
    • RNA Research and Splicing

Papers in

    • Ubiquitin and proteasome pathways 10
    • Advanced biosensing and bioanalysis techniques 8
    • Angiogenesis and VEGF in Cancer 8
    • Protein Degradation and Inhibitors 7
    • RNA modifications and cancer 6
    • RNA and protein synthesis mechanisms 6
    • NF-κB Signaling Pathways 6

Yanling Chen

120 papers receiving 2.6k citations

Hit Papers

Zebrafish as a model system to study toxicology 2013 · 441 citations
4412013202620172021100200300400

Peers

Yanling Chen
Comparison fields: 5 of 149
  • Molecular Biology 1.4k
  • Cancer Research 270
  • Molecular Medicine 89
  • Health, Toxicology and Mutagenesis 234
  • Oncology 365
Replace Bing Li with:
Bing Li China
Yuqi Wang China
Paula A. Oliveira Portugal
Fei Shi China
Gary Guishan Xiao United States
Wenjing Zhang China
Jin Young Kim South Korea
Luca Federici Italy
Jeng‐Fan Lo Taiwan
Chan‐Wha Kim South Korea
Yanling Chen relative to Bing Li China Bing Li's profile →
Citations per field
00.5×1.5×2.1×
Bing Li · 1×
Citations per year

Countries citing papers authored by Yanling Chen

Since Specialization
Citations

This map shows the geographic impact of Yanling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanling Chen more than expected).

Fields of papers citing papers by Yanling Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanling Chen. The network helps show where Yanling Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Yanling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yanling Chen Line = papers co-authored together Yanling Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20255
2 20251
3 20241
4 20243
5 20244
6 20246
7 20240
8 20240
9 20233
10 20233
11 20226
12 202212
13 202115
14 20196
15
The ways to reduce chemical fertilizer input and increase fertilizer use efficiency in maize in Northeast China.
201811
16 201730
17 201644
18 201421
19 200999
20 200325

About Yanling Chen

Yanling Chen is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Hepatology, having authored 126 papers that have together received 2.6k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), Advanced biosensing and bioanalysis techniques (8 papers), Angiogenesis and VEGF in Cancer (8 papers), Lymphatic System and Diseases (7 papers), Protein Degradation and Inhibitors (7 papers), RNA modifications and cancer (6 papers), NF-κB Signaling Pathways (6 papers) and RNA and protein synthesis mechanisms (6 papers). The work is most often cited by research in Molecular Biology (1.4k citations), Cancer Research (270 citations), Molecular Medicine (89 citations), Health, Toxicology and Mutagenesis (234 citations) and Oncology (365 citations). Yanling Chen has collaborated with scholars based in China, United States and Macao. Frequent co-authors include De‐Sheng Pei, Wan-Ping Bian, Qinkai Li, Na Chen, Yanbo Ma, Yongfang Jia, Yujie Dai, Feifei She, Xiaoqian Wang and Qiang Du. Their work appears in journals such as PLoS ONE, Cancer Research, BMC Cancer, Frontiers in Molecular Biosciences and OncoTargets and Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026